https://www.sirnaomics.com/ 2026-07-14T04:33:46+00:00 daily 1.0000 https://www.sirnaomics.com/en/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/about-us/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/science-pipeline/pipeline/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/information-disclosure/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/information-disclosure/announcements-and-circulars/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/information-disclosure/financial-reports/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/information-disclosure/listing-documents/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/information-disclosure/esg-reports/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/corporate-governance/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/stock-information/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/investor-relations/investor-enquiries/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/news/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/careers/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/news/press-release/dr-h-fai-poon-ceo-of-sirnaomics-took-the-stage-at-the-oligonucleotides-peptides-world-asia-congress-2026-held-in-singapore-on-june-30/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/news/press-release/sirnaomics-agm-anchoring-recovery-charting-long-term-value-with-six-strategies/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/en/news/press-release/20260622/ 2026-07-14T04:33:46+00:00 daily 0.8000 https://www.sirnaomics.com/cn/investor-relations/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/en/investor-relations/events-presentations/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/information-disclosure/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/information-disclosure/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/media/n2yah0tr/hkex-eps_20260424_12121146_0-1.pdf 2026-06-23T10:28:05+00:00 daily 0.6400 https://www.sirnaomics.com/media/in4cgv0d/hkex-eps_20250905_11831976_0.pdf 2026-06-23T10:26:29+00:00 daily 0.6400 https://www.sirnaomics.com/media/cfnpijym/hkex-eps_20250425_11644046_0.pdf 2026-06-23T10:24:28+00:00 daily 0.6400 https://www.sirnaomics.com/media/5nuais1d/e_894589_sirnaomics-b_ir2024_0924_1536_ess.pdf 2026-06-23T10:21:09+00:00 daily 0.6400 https://www.sirnaomics.com/media/b2hdb5qk/2023-annual-report-english.pdf 2026-06-23T10:24:03+00:00 daily 0.6400 https://www.sirnaomics.com/media/obmhaedq/sirnaomics-ltd-interim-report-2023.pdf 2026-06-23T10:28:24+00:00 daily 0.6400 https://www.sirnaomics.com/media/1niek5i5/sirnaomics-ltd-2022-annual-report.pdf 2026-06-23T10:19:58+00:00 daily 0.6400 https://www.sirnaomics.com/media/gllfukww/2022-interim-report.pdf 2026-06-23T10:25:52+00:00 daily 0.6400 https://www.sirnaomics.com/media/kgegxd0b/2021annual-report.pdf 2026-06-23T10:27:03+00:00 daily 0.6400 https://www.sirnaomics.com/media/4ecogjbf/global-offering-01.pdf 2026-06-23T10:20:43+00:00 daily 0.6400 https://www.sirnaomics.com/media/jq4ldenp/global-offering-02.pdf 2026-06-23T10:26:55+00:00 daily 0.6400 https://www.sirnaomics.com/media/3wij1ude/global-offering.pdf 2026-06-23T10:20:36+00:00 daily 0.6400 https://www.sirnaomics.com/media/vvmnbf3q/green-application-form.pdf 2026-06-23T10:30:42+00:00 daily 0.6400 https://www.sirnaomics.com/media/ixwl0sbg/hkex-eps_20260424_12121160_0.pdf 2026-06-23T10:26:38+00:00 daily 0.6400 https://www.sirnaomics.com/media/qfghsegp/hkex-eps_20250425_11644048_0.pdf 2026-06-23T10:29:01+00:00 daily 0.6400 https://www.sirnaomics.com/media/zedpk0hx/2023-esg-report-english.pdf 2026-06-23T10:31:37+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/information-disclosure/announcements-and-circulars/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/information-disclosure/announcements-and-circulars/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/information-disclosure/financial-reports/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/information-disclosure/financial-reports/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/information-disclosure/listing-documents/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/information-disclosure/listing-documents/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/information-disclosure/esg-report/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/information-disclosure/esg-report/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/corporate-governance/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/corporate-governance/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/media/1eyftcbb/seagull-nomination-policy.pdf 2026-06-23T10:19:54+00:00 daily 0.6400 https://www.sirnaomics.com/media/hx1htchy/terms-of-reference-of-the-remuneration-committee-under-the-board-of-directors.pdf 2026-06-23T10:26:18+00:00 daily 0.6400 https://www.sirnaomics.com/media/a25e1bhe/terms-of-reference-of-the-nomination-committee-under-the-board-of-directors_20250605.pdf 2026-06-23T10:23:42+00:00 daily 0.6400 https://www.sirnaomics.com/media/gphfphhn/terms-of-reference-of-the-audit-committee-under-the-board-of-directors.pdf 2026-06-23T10:25:56+00:00 daily 0.6400 https://www.sirnaomics.com/media/yy1jkmnh/2026062301517.pdf 2026-06-24T13:51:52+00:00 daily 0.6400 https://www.sirnaomics.com/media/0u2co2wj/2026060500786.pdf 2026-06-24T13:49:15+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/stock-information/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/stock-information/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/investor-enquiries/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/hk/investor-relations/investor-enquiries/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/en/news/press-release/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/en/curent-openings/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/en/news/press-release/20260612/ 2026-07-14T04:33:46+00:00 daily 0.6400 https://www.sirnaomics.com/cn/investor-relations/events-presentations/ 2026-07-14T04:33:46+00:00 daily 0.5120 https://www.sirnaomics.com/hk/investor-relations/events-presentations/ 2026-07-14T04:33:46+00:00 daily 0.5120 https://www.sirnaomics.com/media/azzbod4r/sirnaomics-2023-annual-result-presentation-english.pdf 2026-06-23T10:24:01+00:00 daily 0.5120 https://www.sirnaomics.com/media/suplicuv/stp705-isscc-clinical-phase-update.pdf 2026-06-23T10:29:53+00:00 daily 0.5120 https://www.sirnaomics.com/media/ps0b4f3l/stp705-fat-remodeling-interim-results.pdf 2026-06-23T10:28:53+00:00 daily 0.5120 https://www.sirnaomics.com/media/0vnobubp/hkex-eps_20260424_12121147_0-1.pdf 2026-06-23T10:19:47+00:00 daily 0.5120 https://www.sirnaomics.com/media/swsd0ow4/hkex-eps_20250905_11831977_0.pdf 2026-06-23T10:29:55+00:00 daily 0.5120 https://www.sirnaomics.com/media/omrd5vtg/hkex-eps_20250425_11644047_0.pdf 2026-06-23T10:28:30+00:00 daily 0.5120 https://www.sirnaomics.com/media/oyxjbgdh/c_894589_sirnaomics-b_ir2024_0924_1536_ess.pdf 2026-06-23T10:28:36+00:00 daily 0.5120 https://www.sirnaomics.com/media/lbglsr5p/2023-annual-report-chinese.pdf 2026-06-23T10:27:18+00:00 daily 0.5120 https://www.sirnaomics.com/media/hl4gm2gx/sirnaomics-ltd-2023中期業績報告.pdf 2026-06-23T10:26:09+00:00 daily 0.5120 https://www.sirnaomics.com/media/qmrbshma/sirnaomics-ltd-2022年年度報告.pdf 2026-06-23T10:29:10+00:00 daily 0.5120 https://www.sirnaomics.com/media/0zyaptcw/2022-interim-report-c.pdf 2026-06-23T10:19:49+00:00 daily 0.5120 https://www.sirnaomics.com/media/m42frpl0/2021年度报告.pdf 2026-06-23T10:27:41+00:00 daily 0.5120 https://www.sirnaomics.com/media/mo5j33jh/global-offering-01-cn.pdf 2026-06-23T10:27:53+00:00 daily 0.5120 https://www.sirnaomics.com/media/b1tjoz5d/global-offering-02-cn.pdf 2026-06-23T10:24:05+00:00 daily 0.5120 https://www.sirnaomics.com/media/gyej1zcr/global-offering-cn.pdf 2026-06-23T10:26:01+00:00 daily 0.5120 https://www.sirnaomics.com/media/qc1etig0/green-application-form-cn.pdf 2026-06-23T10:28:57+00:00 daily 0.5120 https://www.sirnaomics.com/media/e4qbd4a1/hkex-eps_20260424_12121161_0.pdf 2026-06-23T10:25:09+00:00 daily 0.5120 https://www.sirnaomics.com/media/knmbhh2r/hkex-eps_20250425_11644049_0-1.pdf 2026-06-23T10:27:06+00:00 daily 0.5120 https://www.sirnaomics.com/media/rz2ohw3e/2023-esg-report-chinese.pdf 2026-06-23T10:29:43+00:00 daily 0.5120 https://www.sirnaomics.com/media/r3rp1qce/2023-annual-report-chinese.pdf 2026-06-23T10:29:21+00:00 daily 0.5120 https://www.sirnaomics.com/media/klipyewy/seagull-提名政策.pdf 2026-06-23T10:27:05+00:00 daily 0.5120 https://www.sirnaomics.com/media/dtcpvemk/董事會薪酬委員會工作細則.pdf 2026-06-23T10:24:54+00:00 daily 0.5120 https://www.sirnaomics.com/media/iprjlknt/terms-of-reference-of-the-nomination-committee-under-the-board-of-directors_20250605-c.pdf 2026-06-23T10:26:31+00:00 daily 0.5120 https://www.sirnaomics.com/media/5e4jxsjk/董事會審核委員會工作細則.pdf 2026-06-23T10:21:02+00:00 daily 0.5120 https://www.sirnaomics.com/media/amtncx0g/第五次經修訂及重列組織章程大綱及細則.pdf 2026-06-23T10:23:50+00:00 daily 0.5120 https://www.sirnaomics.com/media/zdebzxwa/hkex-eps_20250703_11744028_0.pdf 2026-06-23T10:31:36+00:00 daily 0.5120 https://www.sirnaomics.com/en/curent-openings/?page=2 2026-07-14T04:33:46+00:00 daily 0.5120 https://www.sirnaomics.com/en/news/press-release/i-rna-2026-suzhou-summit-2004-pioneering-nucleic-acid-research-bold-exploration-and-rigorous-validation-reshaping-rna-delivery/ 2026-07-14T04:33:46+00:00 daily 0.5120 https://www.sirnaomics.com/media/2epmg3p5/sirnaomics-2023-annual-result-presentation-cn-final.pdf 2026-06-23T10:20:13+00:00 daily 0.4096 https://www.sirnaomics.com/media/1r1na1lm/stp705用于鳞状细胞原位癌的临床进展.pdf 2026-06-23T10:20:05+00:00 daily 0.4096 https://www.sirnaomics.com/media/mbwcxchh/stp705-脂肪重塑中期数据.pdf 2026-06-23T10:27:46+00:00 daily 0.4096 https://www.sirnaomics.com/media/4polvavt/sirnaomics-2023-annual-result-presentation-繁体.pdf 2026-06-23T10:20:49+00:00 daily 0.4096 https://www.sirnaomics.com/en/news/press-release/stp705-phase-ii-validates-pnp-extrahepatic-delivery-stp122g-phase-i-data-shine-in-race-for-first-u-s-fxi-sirna/ 2026-07-14T04:33:46+00:00 daily 0.4096 https://www.sirnaomics.com/en/news/press-release/sirnaomics-innovative-one-drug-two-targets-murna-project-approved-as-lingang-laboratory-scientific-research-task/ 2026-07-14T04:33:46+00:00 daily 0.3277 https://www.sirnaomics.com/en/news/press-release/rnai-as-a-therapeutic-exemplar-mechanism-clinical-progress-and-multifaceted-potential-of-stp705/ 2026-07-14T04:33:46+00:00 daily 0.2621 https://www.sirnaomics.com/en/news/press-release/sirnaomics-核心成果-pnp-递送平台再获验证-筑牢sirna-管线研发核心基石/ 2026-07-14T04:33:46+00:00 daily 0.2097 https://www.sirnaomics.com/en/news/press-release/sirnaomics-stp707-achieves-phase-1-completion-with-fda-csr-submission-iv-rnai-therapy-proves-safe-tumor-microenvironment-targeting-for-refractory-solid-tumors/ 2026-07-14T04:33:46+00:00 daily 0.1678 https://www.sirnaomics.com/en/news/press-release/hangzhou-fuyang-to-launch-rmb-300-million-fund-targeting-sirna-therapeutics-ecosystem/ 2026-07-14T04:33:46+00:00 daily 0.1342 https://www.sirnaomics.com/en/news/press-release/sirnaomics-and-chempartner-forge-strategic-partnership-to-advance-rnai-therapeutics/ 2026-07-14T04:33:46+00:00 daily 0.1074 https://www.sirnaomics.com/en/news/press-release/sirnaomics-has-been-subscribed-for-17-527-696-subscription-shares-new-capital-injection-to-promote-business-growth-and-development/ 2026-07-14T04:33:46+00:00 daily 0.0859 https://www.sirnaomics.com/en/news/press-release/sirnaomics-announces-demonstration-of-a-novel-mechanism-of-action-of-its-sirna-therapeutics-for-focal-fat-reduction-in-journal-of-cosmetic-dermatology/ 2026-07-14T04:33:46+00:00 daily 0.0687 https://www.sirnaomics.com/en/news/press-release/sirnaomics-announces-a-partnership-with-gore-range-capital-for-establishment-of-a-jv-sagesse-bio-to-advance-its-rnai-therapeutics-into-aesthetic-medicine/ 2026-07-14T04:33:46+00:00 daily 0.0550 https://www.sirnaomics.com/en/news/press-release/sirnaomics-announces-completion-of-ind-enabling-studies-of-safety-and-efficacy-for-stp125g-with-nhp-models-targeting-apoc3-for-treatment-of-cardiovascular-diseases/ 2026-07-14T04:33:46+00:00 daily 0.0440 https://www.sirnaomics.com/en/news/press-release/sirnaomics-announces-interim-results-for-successful-completion-of-the-second-cohort-of-phase-i-clinical-study-of-galnac-based-rnai-therapeutic-stp122g-for-anticoagulant-therapeutics/ 2026-07-14T04:33:46+00:00 daily 0.0352 https://www.sirnaomics.com/en/news/press-release/sirnaomics-announces-completion-of-stp707-phase-i-clinical-study-with-strong-safety-profile-and-disease-activity-for-the-treatment-of-pancreatic-cancer-patients/ 2026-07-14T04:33:46+00:00 daily 0.0281 https://www.sirnaomics.com/en/news/press-release/sirnaomics-demonstrates-strong-antitumor-activity-of-its-novel-oligonucleotide-chemo-drug-conjugate-in-journal-of-oncology-research-and-therapy/ 2026-07-14T04:33:46+00:00 daily 0.0225 https://www.sirnaomics.com/en/news/press-release/2024-3-12-sirnaomics-will-present-its-innovative-dual-targeted-galnac-murna-programs-in-2024-opt-conference/ 2026-07-14T04:33:46+00:00 daily 0.0180 https://www.sirnaomics.com/en/news/press-release/20230203sirnaomics-to-present-latest-developments-of-stp705-for-focal-fat-reduction-at-imcas-world-congress-2024/ 2026-07-14T04:33:46+00:00 daily 0.0144 https://www.sirnaomics.com/en/news/press-release/20240124sirnaomics-publishes-novel-mechanism-of-action-of-rnai-cancer-therapeutic-stp-707-for-solid-tumors/ 2026-07-14T04:33:46+00:00 daily 0.0115 https://www.sirnaomics.com/en/news/press-release/20231218rnaimmune-receives-investigational-new-drug-application-clearance-from-u-s-fda-for-mrna-based-respiratory-syncytial-virus-vaccine-rv-1770/ 2026-07-14T04:33:46+00:00 daily 0.0092 https://www.sirnaomics.com/en/news/press-release/20231205sirnaomics-announces-successful-completion-of-cohort-1-from-phase-i-clinical-study-of-galnac-based-rnai-therapeutic-stp122g-for-anticoagulant-treatment/ 2026-07-14T04:33:46+00:00 daily 0.0074 https://www.sirnaomics.com/en/news/press-release/20231201sirnaomics-promotes-francois-lebel-m-d-to-chief-medical-officer/ 2026-07-14T04:33:46+00:00 daily 0.0059 https://www.sirnaomics.com/en/news/press-release/20231101sirnaomics-presents-positive-clinical-data-of-stp705-for-focal-fat-reduction/ 2026-07-14T04:33:46+00:00 daily 0.0047 https://www.sirnaomics.com/en/news/press-release/20231006sirnaomics-invited-to-the-oases-partnership-launch-ceremony-to-become-one-of-the-first-batch-of-strategic-enterprise-partners/ 2026-07-14T04:33:46+00:00 daily 0.0038 https://www.sirnaomics.com/en/news/press-release/20230918sirnaomics-group-moves-into-hong-kong-science-park-to-jointly-write-a-new-chapter-for-biomedicine-development/ 2026-07-14T04:33:46+00:00 daily 0.0030 https://www.sirnaomics.com/en/news/press-release/20230906sirnaomics-to-present-latest-developments-on-its-proprietary-delivery-platform-at-upcoming-industry-conferences/ 2026-07-14T04:33:46+00:00 daily 0.0024 https://www.sirnaomics.com/en/news/press-release/20230906sirnaomics-invited-to-jefferies-asia-forum-2023/ 2026-07-14T04:33:46+00:00 daily 0.0019 https://www.sirnaomics.com/en/news/press-release/20230831sirnaomics-announces-successful-phase-i-clinical-study-of-rnai-therapeutic-stp707-for-treatment-of-multiple-solid-tumors/ 2026-07-14T04:33:46+00:00 daily 0.0015 https://www.sirnaomics.com/en/news/press-release/20230728sirnaomics-appoints-dr-francois-lebel-as-senior-vice-president-for-preclinical-and-clinical-development/ 2026-07-14T04:33:46+00:00 daily 0.0012 https://www.sirnaomics.com/en/news/press-release/20230712sirnaomics-to-present-latest-developments-on-two-proprietary-delivery-platforms-at-upcoming-industry-conferences/ 2026-07-14T04:33:46+00:00 daily 0.0010 https://www.sirnaomics.com/en/news/press-release/20230705sirnaomics-establishes-a-strategic-partnership-with-edirna-inc-an-rna-editing-therapeutic-company/ 2026-07-14T04:33:46+00:00 daily 0.0008 https://www.sirnaomics.com/en/news/press-release/20230619sirnaomics-advances-stp705-for-squamous-cell-carcinoma-in-situ-into-late-stage-clinical-development/ 2026-07-14T04:33:46+00:00 daily 0.0006 https://www.sirnaomics.com/en/news/press-release/20230613sirnaomics-to-present-latest-developments-on-galahead-therapeutic-platform-at-upcoming-industry-conferences/ 2026-07-14T04:33:46+00:00 daily 0.0005 https://www.sirnaomics.com/en/news/press-release/20230605sirnaomics-reports-interim-results-of-stp705-phase-i-clinical-study-for-medical-aesthetics-treatment-in-adults-undergoing-abdominoplasty/ 2026-07-14T04:33:46+00:00 daily 0.0004 https://www.sirnaomics.com/en/news/press-release/20230601-sirnaomics-dosed-the-first-patient-in-phase-i-clinical-study-of-galnac-based-rnai-therapeutic-stp122g-for-anticoagulant-treatment/ 2026-07-14T04:33:46+00:00 daily 0.0003 https://www.sirnaomics.com/en/news/press-release/20230517sirnaomics-to-receive-hk-8-million-subsidy-from-the-hkstp-clinical-translational-catalyst-plan/ 2026-07-14T04:33:46+00:00 daily 0.0003 https://www.sirnaomics.com/en/news/press-release/20230427rnaimmune-receives-fda-clearance-of-investigational-new-drug-application-for-phase-i-trial-of-rv-1730-covid-19-booster-vaccine/ 2026-07-14T04:33:46+00:00 daily 0.0002 https://www.sirnaomics.com/en/news/press-release/20230412sirnaomics-launches-phase-i-clinical-trial-for-galnac-factor-xi-program/ 2026-07-14T04:33:46+00:00 daily 0.0002 https://www.sirnaomics.com/en/news/press-release/20230322sirnaomics-2022-annual-results-presentation/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20230320sirnaomics-to-present-latest-developments-in-polypeptide-nanoparticle-platform-at-the-4th-annual-rnai-based-therapeutics-summit/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20230207-rnaimmune-mrna-cancer-vaccine-program-accepted-for-oral-presentation-at-the-2023-aacr-annual-meeting/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20230201-sirnaomics-accelerates-clinical-development-of-stp705-for-the-treatment-of-non-melanoma-skin-cancers/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221220sirnaomics-announces-interim-data-from-phase-i-clinical-trial-of-rnai-therapeutic-stp707-for-treatment-of-multiple-solid-tumors/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221209sirnaomics-marks-15th-anniversary-with-opening-of-new-us-headquarters-and-laboratories-in-germantown-maryland/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221214sirnaomics-announces-positive-interim-data-from-phase-iib-clinical-trial-of-stp705-in-adults-with-cutaneous-squamous-cell-carcinoma-in-situ/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221213sirnaomics-executive-director-dr-xiaochang-dai-to-deliver-keynote-speech-at-biohk2022/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221107sirnaomics-doses-the-first-patient-in-phase-i-clinical-trial-of-rnai-therapeutic-stp705-in-adults-undergoing-abdominoplasty-for-medical-aesthetics-treatment/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20221025sirnaomics-including-rnaimmune-2022-stakeholder-survey/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220920sirnaomics-to-present-latest-developments-on-sirna-therapeutics-for-cancer-and-galahead-platform-programs-at-the-2nd-annual-oligonucleotide-therapeutics-and-delivery-conference/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220906-sirnaomics-to-present-at-3rd-annual-jefferies-asia-forum/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220829sirnaomics-achieves-100-complete-response-in-phase-ii-clinical-trial-of-stp705-for-treatment-of-cutaneous-basal-cell-carcinoma/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220826-sirnaomics-advances-galahead-based-rnai-therapeutics-for-treatment-of-complement-related-diseases/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220823-sirnaomics-2022-interim-results-presentation-will-be-held-on-31-august-2022/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220819-ecoming-a-constituent-of-hang-seng-family-of-indexes/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220818sirnaomics-doses-the-first-patient-in-phase-i-ii-clinical-study-of-rnai-therapeutic-stp705-for-treatment-of-facial-squamous-cell-skin-cancer-in-situ/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220815-sirnaomics-develops-peptide-docking-vehicle-pdov-designed-for-an-enhanced-galnac-delivery-platform-for-novel-sirna-therapeutics-3/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220726sirnaomics-receives-ind-clearance-from-the-taiwan-ministry-of-health-and-welfare-for-phase-i-clinical-study-of-rnai-therapeutic-stp705-for-liver-cancer-treatment/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220621sirnaomics-to-present-the-latest-developments-of-dual-targeted-rnai-therapeutics-based-on-its-proprietary-galahead-program-at-the-4th-annual-rna-therapeutic-from-concept-to-clinic-symposium/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220616sirnaomics-announces-publication-of-stp705-clinical-study-results-for-treatment-of-isscc-in-the-peer-reviewed-journal-of-drugs-in-dermatology/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/0530-sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp705-in-adults-undergoing-abdominoplasty-for-medical-cosmetology-treatment/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220520-sirnaomics-will-present-clinical-study-results-and-development-strategy-for-cancer-rna-therapeutics-at-the-2022-pre-asco-china-summit/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220511sirnaomics-to-present-latest-developments-on-its-galnac-based-liver-targeting-platforms-and-galahead-programs-at-the-tides-usa-2022/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220404sirnaomics-doses-first-subject-in-phase-i-clinical-trial-of-stp707-for-the-treatment-of-liver-fibrosis-in-primary-sclerosing-cholangitis-1/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220330-rnaimmune-secures-27-million-series-a-round-of-financing-for-development-of-mrna-therapeutics-and-vaccines-1/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220315-sirnaomics-to-present-latest-developments-on-its-galnac-based-liver-targeting-platforms-and-product-pipeline-at-the-2022-oligonucleotide-precision-therapeutics-congress/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220223sirnaomics-announces-interim-data-from-phase-ii-clinical-trial-of-stp705-for-treatment-of-cutaneous-basal-cell-carcinoma/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220215sirnaomics-receives-safe-to-proceed-letter-for-u-s-fda-ind-application/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20220209sirnaomics-launches-phase-i-clinical-trial-of-rnai-therapeutic-stp707-delivered-systemically-for-the-treatment-of-solid-tumors-1/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20211230/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20211215/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20211122/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20211115/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20211018/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210921/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210714/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210706/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210701/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210630/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210624/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210616/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210429/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210426/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210421/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210418/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210203/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20210117/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20201220/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20201203/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20201022/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200830/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200827/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200824/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200620/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200611/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200409/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200304/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200219/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200210/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200128/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200127/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200124/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200113/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20200107/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20191101/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20191024/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20191019/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190603/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190516/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190408/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190311/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190225/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190130/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20190106/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20181220/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180925/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180820/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180816/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180810/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180727/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180606/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20180503/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20171207/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20171206/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20171006sirnaomics-publishes-results-showing-dual-targeting-effects/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170801/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170615/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170602/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170501/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170216/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20170206/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20161107/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20160504/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20160121/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20150105/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20140708/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20140625/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20121219/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20120628/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20120625/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20120228/ 2026-07-14T04:33:46+00:00 daily 0.0001 https://www.sirnaomics.com/en/news/press-release/20100624/ 2026-07-14T04:33:46+00:00 daily 0.0001